JNJ

167.52

-0.36%↓

NVS

117.07

-0.07%↓

ABT

128.81

+1.43%↑

TMO

478.5

-1.61%↓

ISRG

501.25

+0.6%↑

JNJ

167.52

-0.36%↓

NVS

117.07

-0.07%↓

ABT

128.81

+1.43%↑

TMO

478.5

-1.61%↓

ISRG

501.25

+0.6%↑

JNJ

167.52

-0.36%↓

NVS

117.07

-0.07%↓

ABT

128.81

+1.43%↑

TMO

478.5

-1.61%↓

ISRG

501.25

+0.6%↑

JNJ

167.52

-0.36%↓

NVS

117.07

-0.07%↓

ABT

128.81

+1.43%↑

TMO

478.5

-1.61%↓

ISRG

501.25

+0.6%↑

JNJ

167.52

-0.36%↓

NVS

117.07

-0.07%↓

ABT

128.81

+1.43%↑

TMO

478.5

-1.61%↓

ISRG

501.25

+0.6%↑

Search

CONMED Corp

Ouvert

SecteurSoins de santé

50.27 -0.48

Résumé

Variation du prix de l'action

24h

Actuel

Min

49.39

Max

50.79

Chiffres clés

By Trading Economics

Revenu

-28M

6M

Ventes

-25M

321M

P/E

Moyenne du Secteur

12.491

38.156

BPA

0.95

Rendement du dividende

1.68

Marge bénéficiaire

1.879

Employés

3,900

EBITDA

-36M

34M

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+27.92% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

1.68%

2.50%

Prochains Résultats

30 juil. 2025

Date du Prochain Dividende

3 oct. 2025

Date du Prochain Détachement de Dividende

15 sept. 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-508M

1.5B

Ouverture précédente

50.75

Clôture précédente

50.27

Sentiment de l'Actualité

By Acuity

50%

50%

157 / 375 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Very Strong Bullish Evidence

CONMED Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

29 juil. 2025, 23:57 UTC

Acquisitions, Fusions, Rachats

EQT: To Spend Y407.82B for Tender Offer

29 juil. 2025, 23:56 UTC

Acquisitions, Fusions, Rachats

EQT: Tender Offer Price Is Y5,700 a Share

29 juil. 2025, 23:54 UTC

Acquisitions, Fusions, Rachats

EQT To Start Tender Offer for Fujitec

29 juil. 2025, 23:50 UTC

Market Talk

Nikkei May Fall Amid Uncertainty Over Earnings, Domestic Politics -- Market Talk

29 juil. 2025, 23:36 UTC

Market Talk

Gold Steady Ahead of FOMC Decision -- Market Talk

29 juil. 2025, 22:57 UTC

Market Talk

Perseus May Step Up Capital Management at FY 2025 Result -- Market Talk

29 juil. 2025, 22:50 UTC

Market Talk

Mondelez Warns of Price Increases in North America -- Market Talk

29 juil. 2025, 22:44 UTC

Acquisitions, Fusions, Rachats

St Barbara: Potential Divestment of Nova Scotia Ops to be Weighed in 1Q FY26

29 juil. 2025, 22:41 UTC

Acquisitions, Fusions, Rachats

St Barbara FY25 All-in Sustaining Cost A$4,582/Oz

29 juil. 2025, 22:41 UTC

Acquisitions, Fusions, Rachats

St Barbara 4Q All-in Sustaining Cost A$4,613/Oz

29 juil. 2025, 22:35 UTC

Résultats

IGO Maintains Nova Life of Mine Production Guidance

29 juil. 2025, 22:35 UTC

Résultats

IGO Expects FY 2026 Greenbushes Output of 1.50 Million-1.65 Million Tons

29 juil. 2025, 22:35 UTC

Résultats

IGO Expects FY 2026 Greenbushes Cash Costs of A$310-A$360/Ton

29 juil. 2025, 22:34 UTC

Résultats

IGO Expects Train 1 of Kwinana Refinery to Be Fully Impaired

29 juil. 2025, 22:34 UTC

Résultats

IGO Expects to Impair Kwinana Refinery Assets by A$70 Million-A$90 Million

29 juil. 2025, 22:34 UTC

Market Talk
Résultats

Mondelez Snack Demand Holding Up Better in Europe Than U.S. -- Market Talk

29 juil. 2025, 22:33 UTC

Résultats

IGO Had A$279.7 Million of Cash at End-June

29 juil. 2025, 22:33 UTC

Résultats

IGO 4Q Underlying Free Cash A$2.4 Million

29 juil. 2025, 22:33 UTC

Résultats

IGO FY Sales Revenue A$512.5 Million

29 juil. 2025, 22:33 UTC

Résultats

IGO 4Q Sales Revenue A$126.9 Million, Up 15% on 3Q

29 juil. 2025, 22:32 UTC

Résultats

IGO FY Nickel Production 17,173 Tons

29 juil. 2025, 22:32 UTC

Résultats

IGO 4Q Nickel Production 5,107 Tons, Up 22% on 3Q

29 juil. 2025, 22:32 UTC

Résultats

IGO 4Q Lithium Hydroxide Production 2,126 Tons, Up 36% on 3Q

29 juil. 2025, 22:31 UTC

Market Talk
Résultats

Global Equities Roundup: Market Talk

29 juil. 2025, 22:31 UTC

Market Talk
Résultats

Mondelez Sees Consumers Trading Down, Buying in Bulk -- Market Talk

29 juil. 2025, 22:31 UTC

Résultats

IGO 4Q Spodumene Cash Cost A$366/Ton, Up 7% on 3Q

29 juil. 2025, 22:31 UTC

Résultats

IGO FY Spodumene Production 1.48 Million Tons

29 juil. 2025, 22:30 UTC

Résultats

IGO 4Q Spodumene Production 340,000 Tons, Flat on 3Q

29 juil. 2025, 22:30 UTC

Résultats

IGO 4Q Underlying Ebitda A$62 Million

29 juil. 2025, 22:22 UTC

Résultats

Starbucks Abandons Mobile Order, Pickup-Only Stores -- WSJ

Comparaison

Variation de prix

CONMED Corp prévision

Objectif de Prix

By TipRanks

27.92% hausse

Prévisions sur 12 Mois

Moyen 64.33 USD  27.92%

Haut 80 USD

Bas 55 USD

Basé sur 5 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

5 ratings

1

Achat

4

Maintien

0

Vente

Score Technique

By Trading Central

51 / 58.13Support & Résistance

Court Terme

Very Strong Bullish Evidence

Moyen Terme

Bullish Evidence

Long Terme

Strong Bearish Evidence

Sentiment

By Acuity

157 / 375Classement par Soins de santé

Sentiment de l'Actualité

Neutral

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos CONMED Corp

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. The company also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, it offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.